Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis | Scientific Reports
White blood cell growth factors (G/GM-CSF) A practice guidelines Prof. Dr. Khaled Abouelkhair, PhD Medical Oncology SCE, Royal College, UK Ass. Professor. - ppt download
CSF mobilizing protocols employed: dosage and duration; number of... | Download Scientific Diagram
G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis - Document - Gale OneFile: Health and Medicine
Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice - ScienceDirect
Blood Advances on Twitter: "There is a maximum effective G-CSF dose for PBSC mobilization in obese and severely obese donors, above which higher doses add no benefit. #stemcell https://t.co/8eUp3Td1Bb https://t.co/Uk9mzmNcgE" / Twitter
Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer who received adjuvant docetaxel plus cyclophosphamide chemotherapy: a retrospective ...
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy | BMC Cancer | Full Text
PDF) Filgrastim (r-metHuG-CSF): the first 10 years
Hematopoietic Growth Factors in the Management of Anemia and Febrile Neutropenia. - Abstract - Europe PMC
Intermediate-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor Is a Valid Alternative to High-Dose Cyclophosphamide for Mobilizing Peripheral Blood CD34+ Cells in Patients with Multiple Myeloma | Semantic Scholar
Effect of every day (days 1-5) dosing of G-CSF and G-CSF/IgG1-FcL on... | Download Table
Post-G-CSF peripheral blood CD 34 + cell counts and CD 34 + apheresis... | Download Table
HumanKine® recombinant human G-CSF protein- GMP grade | Proteintech
PDF) The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization:
Launch of Sustained-Duration G-CSF Product G-Lasta® in Japan - Kyowa Kirin
GSCF Guideline from the PIER Network - PAEDIATRIC INNOVATION, EDUCATION & RESEARCH NETWORK
Cell recovery (10 3 mm -3 ) before, throughout and after G-CSF treatment | Download Table
Pharmacy sales prices of G-CSF products. | Download Table
Table 2 from Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey | Semantic Scholar
Proposed daily G-CSF dosage for healthy donors Donor's body weight... | Download Table
img028.GIF
GSCF Guideline from the PIER Network - PAEDIATRIC INNOVATION, EDUCATION & RESEARCH NETWORK
For Hematologic Toxicities - FOLOTYN.com - HCP Site
Granulocyte-colony-stimulating factor dosing by donor center No. of... | Download Table
